The clinical course of progressive bulbar palsy

Chafic Karam, Stephen N. Scelsa, Daniel J L MacGowan

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Our objective was to study the clinical course of patients diagnosed with progressive bulbar palsy (PBP). We reviewed all 392 medical records of ALS patients seen between 1 January 2000 and 31 July 2007. Patients with isolated PBP at presentation were selected and classified into those with normal EMG of the limbs (PBP-N) and those with active denervation on EMG (PBP-A). We studied the time to progression of these patients to ALS. We compared patients with PBP-N to patients with PBP-A. Fifteen patients were diagnosed with PBP-N. The remaining 17 had PBP-A. Thirteen of the 15 patients with PBP-N (87%) progressed to definite ALS. The two patients who did not progress to ALS died at 22 and 60 months, respectively. The median survival time was 35 months for the PBP-N group and 40 months for the PBP-A group (p = 0.92). Except for the rate of depression, patients with PBP-N did not differ from patients with PBP-A in the basic demographics, time of presentation, clinical course, survival and treatment received. All patients with FTD died within 40 months of onset of symptoms. In conclusion, almost all PBP patients progress to ALS regardless of the presence of upper motor signs or generalized denervation on EMG of the limbs.

Original languageEnglish (US)
Pages (from-to)364-368
Number of pages5
JournalAmyotrophic Lateral Sclerosis
Volume11
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Progressive Bulbar Palsy
Denervation
Extremities
Survival

Keywords

  • Amyotrophic lateral sclerosis
  • Frontotemporal dementia
  • Progressive bulbar palsy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

The clinical course of progressive bulbar palsy. / Karam, Chafic; Scelsa, Stephen N.; MacGowan, Daniel J L.

In: Amyotrophic Lateral Sclerosis, Vol. 11, No. 4, 2010, p. 364-368.

Research output: Contribution to journalArticle

Karam, Chafic ; Scelsa, Stephen N. ; MacGowan, Daniel J L. / The clinical course of progressive bulbar palsy. In: Amyotrophic Lateral Sclerosis. 2010 ; Vol. 11, No. 4. pp. 364-368.
@article{9484603db0de4202b2f81434654b861d,
title = "The clinical course of progressive bulbar palsy",
abstract = "Our objective was to study the clinical course of patients diagnosed with progressive bulbar palsy (PBP). We reviewed all 392 medical records of ALS patients seen between 1 January 2000 and 31 July 2007. Patients with isolated PBP at presentation were selected and classified into those with normal EMG of the limbs (PBP-N) and those with active denervation on EMG (PBP-A). We studied the time to progression of these patients to ALS. We compared patients with PBP-N to patients with PBP-A. Fifteen patients were diagnosed with PBP-N. The remaining 17 had PBP-A. Thirteen of the 15 patients with PBP-N (87{\%}) progressed to definite ALS. The two patients who did not progress to ALS died at 22 and 60 months, respectively. The median survival time was 35 months for the PBP-N group and 40 months for the PBP-A group (p = 0.92). Except for the rate of depression, patients with PBP-N did not differ from patients with PBP-A in the basic demographics, time of presentation, clinical course, survival and treatment received. All patients with FTD died within 40 months of onset of symptoms. In conclusion, almost all PBP patients progress to ALS regardless of the presence of upper motor signs or generalized denervation on EMG of the limbs.",
keywords = "Amyotrophic lateral sclerosis, Frontotemporal dementia, Progressive bulbar palsy",
author = "Chafic Karam and Scelsa, {Stephen N.} and MacGowan, {Daniel J L}",
year = "2010",
doi = "10.3109/17482960903513159",
language = "English (US)",
volume = "11",
pages = "364--368",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - The clinical course of progressive bulbar palsy

AU - Karam, Chafic

AU - Scelsa, Stephen N.

AU - MacGowan, Daniel J L

PY - 2010

Y1 - 2010

N2 - Our objective was to study the clinical course of patients diagnosed with progressive bulbar palsy (PBP). We reviewed all 392 medical records of ALS patients seen between 1 January 2000 and 31 July 2007. Patients with isolated PBP at presentation were selected and classified into those with normal EMG of the limbs (PBP-N) and those with active denervation on EMG (PBP-A). We studied the time to progression of these patients to ALS. We compared patients with PBP-N to patients with PBP-A. Fifteen patients were diagnosed with PBP-N. The remaining 17 had PBP-A. Thirteen of the 15 patients with PBP-N (87%) progressed to definite ALS. The two patients who did not progress to ALS died at 22 and 60 months, respectively. The median survival time was 35 months for the PBP-N group and 40 months for the PBP-A group (p = 0.92). Except for the rate of depression, patients with PBP-N did not differ from patients with PBP-A in the basic demographics, time of presentation, clinical course, survival and treatment received. All patients with FTD died within 40 months of onset of symptoms. In conclusion, almost all PBP patients progress to ALS regardless of the presence of upper motor signs or generalized denervation on EMG of the limbs.

AB - Our objective was to study the clinical course of patients diagnosed with progressive bulbar palsy (PBP). We reviewed all 392 medical records of ALS patients seen between 1 January 2000 and 31 July 2007. Patients with isolated PBP at presentation were selected and classified into those with normal EMG of the limbs (PBP-N) and those with active denervation on EMG (PBP-A). We studied the time to progression of these patients to ALS. We compared patients with PBP-N to patients with PBP-A. Fifteen patients were diagnosed with PBP-N. The remaining 17 had PBP-A. Thirteen of the 15 patients with PBP-N (87%) progressed to definite ALS. The two patients who did not progress to ALS died at 22 and 60 months, respectively. The median survival time was 35 months for the PBP-N group and 40 months for the PBP-A group (p = 0.92). Except for the rate of depression, patients with PBP-N did not differ from patients with PBP-A in the basic demographics, time of presentation, clinical course, survival and treatment received. All patients with FTD died within 40 months of onset of symptoms. In conclusion, almost all PBP patients progress to ALS regardless of the presence of upper motor signs or generalized denervation on EMG of the limbs.

KW - Amyotrophic lateral sclerosis

KW - Frontotemporal dementia

KW - Progressive bulbar palsy

UR - http://www.scopus.com/inward/record.url?scp=77953802170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953802170&partnerID=8YFLogxK

U2 - 10.3109/17482960903513159

DO - 10.3109/17482960903513159

M3 - Article

C2 - 20132084

AN - SCOPUS:77953802170

VL - 11

SP - 364

EP - 368

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - 4

ER -